SciELO - Scientific Electronic Library Online

 
vol.24 issue2IL1B-511 and TNF-A-308 polymorphisms in a population infected with Helicobacter pylori from a low-risk area of gastric cancer in Nariño-ColombiaTourniquets used in peripheral venipuncture as a potential vehicle for transmission of microorganisms: scoping review author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Infectio

Print version ISSN 0123-9392

Infect. vol.24 no.2 Bogotá Apr./June 2020

https://doi.org/10.22354/in.v24i2.838 

ARTÍCULO ORIGINAL

HIV infection prevalence and associated risk factors in people who inject drugs in Medellin

Prevalencia de infección por VIH y factores de riesgo asociados, en personas que se inyectan drogas en la ciudad de Medellín

Heidy Johanna Contreras1  * 

Ana María Hoyos2 

Daniel Alberto Gómez2 

Laura María Roldán2 

Susana Huacuja2 

Dedsy Yajaira Berbesí1 

Angela María Segura2 

Guillermo Alonso Castaño2 

Pedro Mateu-Gelabert3 

1Universidad CES. Medellín Colombia.

2Estudiantes de medicina. Interno. Universidad CES. Medellín Colombia.

3National Development and Research Institutes, Inc., New York, USA.


Abstract

Introduction:

the availability of high purity and low-cost drugs has increased the use of intravenous substances, which makes it a public health problem due to its association with HIV infection.

Objective:

to identify the factors associated with HIV infection in people who inject drugs.

Materials and methods:

a cross-sectional descriptive study was carried out between December 2017 and January 2018 in Medellin, Colombia. We use the sampling conducted by the respondent (RDS).

Results:

They have recruited 224 subjects, 86.2% were men, 82.0% were single and 67.0% belonged to the subsidized or linked health system. The prevalence of HIV infection was 3.6%. This study found that 38.8% of consumers have shared needles and syringes with up to three people, representing a risk of infection of 5.07 times, compared to those who do not share (RPc = 5.07 95% CI: 1.19-21.55), and if this practice is carried out with a close friend, the probability increases to almost double (10.69) (RPc = 10.69 IC 95%: 2.26-50.61) (p <0.05).

Conclusion:

Given the low prevalence of HIV, it is vital to develop and implement public policies whose objective is to create prevention programs that ultimately lead to the reduction of infection in this population.

Keywords: HIV; Needles; Heroin; Infection; Acquired immunodeficiency syndrome; risk; Health; population; transmission; drug users

Resumen

Introducción:

La disponibilidad de drogas con una alta pureza y un bajo costo, ha aumentado el consumo de sustancias por vía intravenosa; llevándolo a ser considerado como un problema de salud pública, por su asociación con la presencia de infección por VIH. Se estima que existen aproximadamente 16 millones de consumidores de drogas intravenosas en el mundo y en Colombia, 15.000.

Objetivo:

identificar los factores asociados con la infección por VIH en personas que se inyectan drogas.

Materiales y métodos:

estudio descriptivo transversal, realizado (diciembre 2017/ enero 2018) Medellín - Colombia, se utilizó la metodología Respondent Driven Sampling (RDS).

Resultados:

Fueron reclutados 224 participantes, un 86,2% fueron hombres, el 82,0% eran solteros, el (67,0%) pertenecía al régimen de salud subsidiado o vinculado. Con relación a la prevalencia de infección por VIH esta fue del 3,6%. Este estudio encontró que el 38,8% de los consumidores había compartido agujas y jeringas con hasta tres personas, lo cual representa una probabilidad de 5,07 veces de contraer la infección comparado con aquellos que no comparten (RPc=5,07 CI95% 1,19-21,55), si esta práctica se hace con un amigo cercano dicha probabilidad aumenta a casi el doble 10,69 (RPc= 10,69 CI95% 2,26-50,61), (p<0,05).

Conclusión:

Ante la baja prevalencia de VIH, es necesario, el desarrollo e implementación de políticas públicas que tengan como objetivo la creación de programas de prevención que finalmente, lleven a la reducción de la infección en esta población.

Palabras clave: VIH; Agujas; Heroína; Infección; Síndrome de inmunodeficiencia adquirida; riesgo; salud; población; transmisión; usuarios de drogas

Introduction

Since 1990, the availability of high quality and low cost drugs has incremented exponentially, and as a result, intravenous consumption of these drugs has increased1. Opiates were among the most used substances in 2013 (71.8%)2, making them a current pressing issue for the Colombian Social Protection Ministry taking into account their impact on public health due to their association with the spread of HIV infection3,4. People who inject drugs (PWID) are seven times more likely to get HIV that the general population5.

It is estimated that there are approximately 6 million intravenous drug consumers around the world5. According to the last heroin consumption report in Colombia, there are around 15,000 PWID in the country, which is a worrying figure since the use of this type of drugs entails a higher risk for the health of the consumer6.

In 2017, a non-governmental Colombia reported 13,310 infected people with HIV highlighting sexual contact as the main transmission mechanism (91.4%). Additionally, they observed other mechanisms like injecting drugs with 0.13% (11 cases)7, which was slightly higher than what was reported in 2015 (eight cases), evidencing the importance of following up with this population.

HIV infection in Colombia has been defined as a concentrated epidemic, which means the disease occurs mainly in high vulnerability groups: sex workers, males who have sex with other males (MSM), and PWID, with prevalences higher tan 5%, while for the rest of the population it is below 1%. This concept was established by the World Health Organization7.

It is important to remember that in PWID, the HIV virus spreads much faster than among the general population8, given the fact that sharing syringes has been reported as a factor which increases the risk of acquiring the virus9. The paraphernalia is also highly important when talking about HIV in PWID10.

The study “Determinants of HIV positivity among injecting drugs users in Delhi and Punjab” evidenced that 10% of this virus transmission can be attributed to the use of injected drugs 11. Additionally, with the implementation of risk decrease policies, such as syringe exchange programs, replacement with methadone, peer educational programs, etc., a reduction in the transmission of the virus has occurred 12. This article aimed to identify associated factors with HIV infection in people who inject drugs in Medellin .

Materials and methods

This was a cross-sectional descriptive study of people who inject drugs, conducted between December 2017 and January 2018, in Medellin, Colombia, using the respondent driven sampling (RDS) methodology13. The sample size was calculated with the formula for 5% HIV prevalence proportion in Colombia, with a 95% confidence interval, a design effect of 1, and 5% precision, for a total of 224 participants.

The procedure used for the collection of the information was through the initial selection of three seeds or non-randomized participants from the target population. This selection was made through key informants, which then chose other PWID that complied with the inclusion criteria: at least 18 years old, active consumers (in the last six months), who had consumed psychoactive substances outdoors in Medellin, and finally, those who accepted through signing an informed consent. From these seeds we started the recruiting waves, until completing 224 subjects.

Two types of incentives were given to the participants: a primary incentive or for participating in the study, and a secondary one, linked to the successful participation of three new subjects (an approximate value of USD $4 and $7, respectively). The size of the target sample was reached after approximately eight weeks.

The instrument included questions, such as demographic characteristics, HIV knowledge, injection practices, sexual practices, and injection networks. Following the guidelines of the Colombian guide for HIV diagnosis, those people whose first test was positive were subjected to a second blood collection on filter paper to perform a confirmation test.

As a bias control measure in the interviewees, we carried out a standardizing training prior to gathering the information. We guaranteed the confidentiality of the information provided by the population.

This project was endorsed by the Ethics Committee of the Universidad CES. For the analysis of the data we used SPSS version 21, Universidad CES licence.

Results

We recruited 224 people who injected intravenous drugs in total (N=224), from which 86.2% were men, 82.0% were single, most of them were mestizo and indigenous (84.2%), and 47.3% came from a very low social status. Similarly, we found that 67.0% belonged to a subsidized or linked health regime (table 1). We observed that HIV prevalence among the consumers in the metropolitan area of Medellin was 3.6%.

Table 1 Sociodemographic characteristics of people who inject drugs in Medellin. December 2017- January 2018. 

Among the analyzed factors we found that if the number of friends with whom drugs were consumed before its first injection was around half of them, HIV probability increased 67% (RPc=1.67, 95% CI: 0.184-15.155), compared to when only a few of them consumed drugs. The proportion of users who reported having used syringes used by other people was 37.4%, and they were 1.71 times more likely to present with HIV infection (RPc=1.71, 95% CI: 0.42-7.02) without these associations being statistically significant.

Drug selling on the part users was reported as 63.4%, and a less common practice was to get paid for injecting someone else (21.5%). The latter practice increases 2.27 times the probability of having HIV compared to not doing it (RPc=2.27, 95% CI: 0.52-9.84); said association was not statistically significant.

When asking about HIV knowledge before starting to inject drugs, 85% of the people referred having previous knowledge, with this information being obtained in education institutions 54% of the time. Among the reported knowledge about HIV, 66% said they knew that not sharing injection equipment could prevent infection 2.02 times when compared with sharing the equipment (RPc= 2.02, 95% CI: 0.49-8.32). In regard to living with HIV, 96.6% were concerned.

When talking about reported practices in the last six months, it was found that 38.8% have shared needles and syringes with up to three people, followed by more than three people with 23.2%, and only 13.8% reported not having shared with anyone. Likewise, when comparing the fact of sharing with more than three people, we found that they were 5.07 times more likely to get the infection compared to those who do not share with anyone (RPc=5.07, 95% CI: 1.19-21.55). For the question of whether when they shared syringes they did it with a close friend, if the answer was always, they were 10.69 times more likely to get HIV compared to almost always (RPc=10.69, 95% CI: 2.26-50.61). Said associations were statistically significant (p<0.05) (table 2).

Table2 Factors>associated to the presence of HIV infection in people who inject drugs in the city of Medellín. December 2017 - January 2018. 

*NC: Not calculated

For the multivariate analysis, we included the variables: number of people with which they shared needles or syringes (in the last six months), and whether they have injected with used syringes accompanied by a close friend by statistic criterion of p<0.05. Additionally, we added the variables: has been paid to inject someone else, is worried about living with HIV, place where they usually inject, and injection frequency, by Hosmer and Lemeshow criterion. When adjusting the RP through the logistic regression method, two variables retained the condition of increasing the probability of HIV: place where they usually inject (public space), and has injected with used needles and syringes accompanied by a close friend. Nevertheless, none of them was statistically significant (table 3).

Table 3 Factors that explain the presence of HIV infection in people who inject drugs in the city of Medellín. December 2017 - January 2018 

Discussion

In this research, we found that the majority of the participants were men with a 6:1 ratio, data which is similar to what was reported in the study by Berbesi-Fernández, et al, with a ratio of eight men per each woman5. In the heroin report in Colombia that consolidates the information of all studies carried out until that moment, which was published in 2015, they found a ratio of five men per each woman6.

Regarding socioeconomical stratum, 75% belonged to les privileged strata (low and very low), similar to what was reported by Mateu-Gelabert, et al. in a study done in Pereira and Medellín, where the percentage was 77%15. In regard to marital status, eight out of every 10 PWID in this study stated they were single. This result matches the data of the study by Berbesi-Fernández, et al., which reported a similar figure 3.

As to health registration, in this study we found that 65.6% of the population was registered in the subsidized regime. This result is comparable to the CES series between 2011 and 2014, which was reported in the heroin analysis in Colombia, showing 59.4% of the population in Medellín. Additionally, these two studies agree on the percentage of registered users in the contributory regime, which were 15.6% and 15.3%, respectively6.

Concerning the prevalence of HIV in PWID in the city of Medellín (3.6%), we found that is it higher compared to the report by Berbesí D, et al in 2010, which was only 2% 2, and subsequent studies (2014) showed an increase of up to 6.3%. These data confirm that the prevalence of the infection is low compared to other regions, as reported by United Nations Office on Drugs and Crime (ONODC) in 2016: Africa 11.2%, Asia 12%, and Europe up to 19.1%.

Regarding the consumption related to the risk of infection with HIV, we observed there was a higher prevalence in people who injected daily, as evidence in other studies, such as the report by Ospina-Escobar and Jarlais D14,15.

In this study we showed that there is a significant association between HIV infection and intravenous drug injection with used needles or syringes, which is similar to the results in various studies carried out by the National Health Ministry in Ukraine10,16.

Furthermore, we found that not only sharing equipment was a predisposing factor, but also sharing needles with multiple PWID; for this study, there was a higher chance of presenting with HIV infection when the number was more than three people. In the article by Des Jarlais D, et al., they found a comparable situation in which among the variables that influenced the emergence of new waves of infection by HIV, they included having broad injection networks as a predisposing factor. This is also supported by the report by Phukan S15,17.

This research showed that sharing and reusing injection equipment are associated to the presence of HIV infection. Keeping in mind that strategies to minimize the risk have been described around the world, it is necessary to systematically and regularly adopt those strategies in countries like Colombia, especially in cities like Medellín, since this will reduce the behaviors associated to the presence of the infection. It is essential to implement programs to reduce the harm, including addiction control, promotion of appropriate injection, and peer education to significantly decrease infection rates12.

Conclusion

Injecting drug use has been considered a problem of global public health interest, not only due to its physical and mental consequences, but also because this practice entails a risk of infections like HIV, viral hepatitis, among others. This is a worldwide concern given the fact that this practice is increasingly common among consumers, generating a global warning and the need to develop strategies to protect this population. Among these strategies, there are programs that aim at establishing safe injection methods and practices to protect the health of the consumers. It is now clear that they are not limited to stopping consumption (which is the most difficult objective to attain), but they go as far as recognizing addiction as a health issue. As expected, the inclusion of these programs has not occurred in the same way in all countries; in Colombia, some approximations have been carried out, but they have not been implemented systematically yet.

Punitive approaches aimed at the consumers of psychoactive substances have been known to increase unsafe practices that could mean a rise in the prevalence of HIV infection. On the other hand, if a public health approach is used, strategies that are effective and move toward reducing the damage associated with those practices could be used. As part of the intervention, educational and sterile injection material Access strategies may be put in place to mitigate the damage caused by consumption, as well as reducing costs for the health system in the medium and long-term.

In light of the low prevalence of HIV infection reported in this study, we consider it necessary and appropriate to develop and implement public policies whose objective is to créate prevention and education programs that will eventually lead to the reduction of HIV infection in people who inject drugs, after being refined and adjusted to local needs.

Limitations

Sampling based on the interviewee is considered a type of non-randomized selection that must comply with a series of assumptions to be considered a dependent sample of the social network. This study was not able to include PWID from high socioeconomical strata due to their lack of interest in receiving any kind of incentive for participating in the research.

References

1. Mateu-Gelabert P, Harris S, Berbesi D, Segura Cardona ÁM, Montoya Vélez LP, Mejía Motta IE, et al. Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention. Subst Use Misuse. 28 de enero de 2016;51(2):230-40. [ Links ]

2. Berbesi D, Segura Cardona A, Montoya Vélez L, Mateu Gelabert P. Consumo de heroína inyectada en Colombia y comportamientos de riesgo. Salud Ment. febrero de 2013;36(1):27-31. [ Links ]

3. Berbesí Fernández DY, Montoya Vélez LP, Segura Cardona ÁM, Mateu Gelabert P. Estudio de prevalencia de VIH y comportamientos de riesgo asociados, en usuarios de drogas por vía inyectada (UDI) en Medellín y Pereira. Bogotá: Ministerio de la Protección Social; 2012. [ Links ]

4. Colombia. Ministerio de la Proteccion Social, Colombia. Direccion Nacional de Estupefacientes. Estudio nacional de consumo de sustancias psicoactivas en Colombia 2008: informe final. Bogotá: Ministerio de la Proteccion Social; 2008. [ Links ]

5. Berbesi-Fernández D, Segura-Cardona AM, Montoya-Velez L, LopezRamirez E. Situación de VIH en usuarios de drogas inyectables en Colombia. Infectio. 1 de abril de 2016;20(2):70-6. [ Links ]

6. Colombia. Ministerio de Justicia y del Derecho. La Heroína en Colombia, Producción, uso e impacto en la salud pública - Análisis de la evidencia y recomendaciones de política. Bogotá: LEGIS; 2015. [ Links ]

7. Instituto Nacional de Salud. Informe de evento VIH sida en Colombia 2017. Bogotá: Ministerio de la Proteccion Social ; 2017. [ Links ]

8. Berbesi D, Segura A, Montoya L. Cross-sectional study of HIV prevalence and the characteristics of injecting drug users in Colombia. J Subst Use. 1 de octubre de 2014;19(5):364-7. [ Links ]

9. Saelim A, Geater A, Chongsuvivatwong V, Rodkla A, Bechtel GA. Needle sharing and high-risk sexual behaviors among IV drug users in Southern Thailand. AIDS Patient Care STDs. septiembre de 1998;12(9):707-13. [ Links ]

10. Rossi D, Ralón G. Uso de drogas y VIH : documento de trabajo con orientaciones para la intervención y la investigación. Buenos Aires; 2012. [ Links ]

11. Swain P, Das JK, Jha S, Sharnngadharan GK. Determinants of HIV positivity among injecting drug users in Delhi and Punjab. Indian J Sex Transm Dis AIDS. 2017;38(2):121-7. [ Links ]

12. Chen Y, Tang Z, Tang S, Shen Z, Zhu Q, Li R, et al. Decreasing HIV, Syphilis, and Hepatitis C Infection After a Decade of Harm Reduction Implementation Among Drug Users in Southwestern Areas of China. J Stud Alcohol Drugs. 2018;79(2):248-57. [ Links ]

13. Malekinejad M, Johnston LG, Kendall C, Kerr LRFS, Rifkin MR, Rutherford GW. Using Respondent-Driven Sampling Methodology for HIV Biological and Behavioral Surveillance in International Settings: A Systematic Review. AIDS Behav. julio de 2008;12(S1):105-30. [ Links ]

14. Ospina-Escobar A, Magis-Rodríguez C, Juárez F, Werb D, Bautista Arredondo S, Carreón R, et al. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico. Harm Reduct J. 18 de mayo de 2018;15(1):27. [ Links ]

15. Des Jarlais DC, Kerr T, Carrieri P, Feelemyer J, Arasteh K. HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS Lond Engl. 27 de marzo de 2016;30(6):815-26. [ Links ]

16. Mazhnaya A, Tobin KE, Owczarzak J. Association between injection in public places and HIV/HCV risk behavior among people who use drugs in Ukraine. Drug Alcohol Depend. agosto de 2018;189:125-30. [ Links ]

17. Phukan SK, Medhi GK, Mahanta J, Adhikary R, Thongamba G, Paranjape RS, et al. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India. Harm Reduct J. 03 de 2017;14(1):41. [ Links ]

Cómo citar este artículo: H.J. Contreras, et al. HIV infection prevalence and associated risk factors in people who inject drugs in Medellin. Infectio 2020; 24(2):88-93 http://dx.doi.org/10.22354/in.v24i2.838

Ethical disclosures

Protection of human and animal subjects. This research do not used human nor animal material.

Right to privacy and informed consent. The authors declare that no data that enables identification of the patients appears in this article.

Agradecimientos. damos las gracias a todos los usuarios de drogas inyectables que participaron en el estudio, al equipo de trabajo y las personas que se vincularon en la realización de este proyecto de investigación.

Funding. This research was financed by Colciencias within doctoral call 727.

Received: July 04, 2019; Accepted: December 09, 2019

* Autor para correspondencia. Correo electrónico: hcontreras@ces.edu.co Calle 10A #22-04 Universidad CES. Teléfono: 311 371 09 71

Conflicts of interest.

None declared.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License